Literature DB >> 31975761

Oral Semaglutide.

Sally Hughes1, Joshua J Neumiller1.   

Abstract

Year:  2020        PMID： 31975761      PMCID： PMC6969659          DOI： 10.2337/cd19-0079

Source DB:  PubMed          Journal:  Clin Diabetes        ISSN： 0891-8929


× No keyword cloud information.
  6 in total

Review 1.  Incretin-based therapies.

Authors:  Joshua J Neumiller
Journal:  Med Clin North Am       Date:  2014-10-18       Impact factor: 5.456

2.  Oral Semaglutide Versus Empagliflozin in Patients With Type 2 Diabetes Uncontrolled on Metformin: The PIONEER 2 Trial.

Authors:  Helena W Rodbard; Julio Rosenstock; Luis H Canani; Chaicharn Deerochanawong; Janusz Gumprecht; Søren Østergaard Lindberg; Ildiko Lingvay; Anette Luther Søndergaard; Marianne Bach Treppendahl; Eduard Montanya
Journal:  Diabetes Care       Date:  2019-09-17       Impact factor: 19.112

3.  Oral semaglutide versus subcutaneous liraglutide and placebo in type 2 diabetes (PIONEER 4): a randomised, double-blind, phase 3a trial.

Authors:  Richard Pratley; Aslam Amod; Søren Tetens Hoff; Takashi Kadowaki; Ildiko Lingvay; Michael Nauck; Karen Boje Pedersen; Trine Saugstrup; Juris J Meier
Journal:  Lancet       Date:  2019-06-08       Impact factor: 79.321

4.  Transcellular stomach absorption of a derivatized glucagon-like peptide-1 receptor agonist.

Authors:  Stephen T Buckley; Tine A Bækdal; Andreas Vegge; Stine J Maarbjerg; Charles Pyke; Jonas Ahnfelt-Rønne; Kim G Madsen; Susanne G Schéele; Tomas Alanentalo; Rikke K Kirk; Betty L Pedersen; Rikke B Skyggebjerg; Andrew J Benie; Holger M Strauss; Per-Olof Wahlund; Simon Bjerregaard; Erzsébet Farkas; Csaba Fekete; Flemming L Søndergaard; Jeanett Borregaard; Marie-Louise Hartoft-Nielsen; Lotte Bjerre Knudsen
Journal:  Sci Transl Med       Date:  2018-11-14       Impact factor: 17.956

Review 5.  9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes-2019.

Authors: 
Journal:  Diabetes Care       Date:  2019-01       Impact factor: 19.112

6.  Effect of Oral Semaglutide Compared With Placebo and Subcutaneous Semaglutide on Glycemic Control in Patients With Type 2 Diabetes: A Randomized Clinical Trial.

Authors:  Melanie Davies; Thomas R Pieber; Marie-Louise Hartoft-Nielsen; Oluf K H Hansen; Serge Jabbour; Julio Rosenstock
Journal:  JAMA       Date:  2017-10-17       Impact factor: 56.272
  6 in total
  2 in total

Review 1.  The potential role of incretin-based therapies for polycystic ovary syndrome: a narrative review of the current evidence.

Authors:  Mohammed Altigani Abdalla; Harshal Deshmukh; Stephen Atkin; Thozhukat Sathyapalan
Journal:  Ther Adv Endocrinol Metab       Date:  2021-01-27       Impact factor: 3.565

2.  Switching between GLP-1 receptor agonists in clinical practice: Expert consensus and practical guidance.

Authors:  Akshay B Jain; Amar Ali; Juan J Gorgojo Martínez; Irene Hramiak; Ketan Kavia; Sten Madsbad; Louis Potier; Ben D Prohaska; Jodi L Strong; Tina Vilsbøll
Journal:  Int J Clin Pract       Date:  2020-11-03       Impact factor: 2.503
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.